This inventor holds 11 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Takeda Pharmaceutical Company Limited, Sumitomo Pharma Switzerland Gmbh, Myovant Sciences Gmbh. Active years: 2019-2026.
Company Filing History:
10 out of 1,226 
5 out of 6 
4 out of 6 Years Active: 2019-2026
Title: Paul N Mudd, Jr: Innovator in Pharmaceutical Treatments
Introduction
Paul N Mudd, Jr. is a notable inventor based in Cary, NC (US), recognized for his contributions to pharmaceutical innovations. He holds a total of 11 patents, focusing on treatments for various medical conditions, particularly in urology and oncology.
Latest Patents
Among his latest patents, Mudd has developed Vibegron for the treatment of overactive bladder symptoms. This method involves orally administering an amount of vibegron ranging from about 60 mg to about 90 mg per day to men suffering from benign prostatic hyperplasia. Additionally, he has worked on methods for treating prostate cancer, which include administering at least 80 mg of a specific compound once daily, as well as a regimen involving an oral load dose formulation followed by a maintenance dose.
Career Highlights
Mudd has had a significant career in the pharmaceutical industry, working with prominent companies such as Takeda Pharmaceutical Company Limited and Sumitomo Pharma Switzerland GmbH. His work has contributed to advancements in medical treatments that improve patient outcomes.
Collaborations
Throughout his career, Mudd has collaborated with various professionals, including Vijaykumar Reddy Rajasekhar and Brendan Mark Johnson. These collaborations have likely enhanced the development and implementation of his innovative treatments.
Conclusion
Paul N Mudd, Jr. stands out as a key figure in the field of pharmaceutical inventions, with a focus on improving treatments for overactive bladder symptoms and prostate cancer. His contributions continue to impact the medical community positively.